The basis for updates for the 9th edition of UICC TNM classification of malignant diseases
The basis for updates for the 9th edition of UICC TNM classification of malignant diseases
Zolbetuximab plus chemo in CLDN18.2-positive metastatic pancreatic cancer does not improve OS
ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas
Defining breast cancer quality care around the globe
Novel therapies in mCRPC: Tarlatamab targeting DLL3 shows early activity in neuroendocrine mCRPC
Highlights from APCCC 2026
Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy
Development and challenges for T-cell engagers as a novel treatment for lung cancer and mesothelioma
Education and training in breast cancer care
QoL outcomes are inconsistently reported in contemporary phase III genitourinary cancer trials
The Vanessa Moss Prize: celebrating research into cancer health disparities
Can public–private partnerships accelerate cancer research and clinical trials in LMICs?